ADUS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the data provided, Addus Homecare Corp (ADUS) is not a strong buy for a beginner, long-term investor at this time. While the company has shown strong financial performance in its latest quarter, the lack of positive trading signals, neutral trading sentiment, and recent downward revisions in analyst price targets suggest limited immediate upside potential. Holding the stock or waiting for a better entry point may be more prudent.
The MACD is positive and expanding, suggesting bullish momentum. RSI is neutral at 55.088, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot point of 93.517, with resistance at 95.495 and support at 91.538.
Strong financial performance in Q4 2025, with revenue up 25.55% YoY, net income up 52.52% YoY, and EPS up 50.47% YoY.
No recent news or significant event-driven catalysts. Analyst price targets have been revised downward multiple times recently, and the stock has an Underweight rating from Barclays. Gross margin dropped by 3.18% YoY.
In Q4 2025, Addus Homecare reported revenue of $373.08M (+25.55% YoY), net income of $29.78M (+52.52% YoY), and EPS of $1.61 (+50.47% YoY). However, gross margin declined to 32.02% (-3.18% YoY).
Barclays has an Underweight rating with a price target lowered to $102 from $112. Stephens has an Overweight rating but also lowered its price target to $135 from $140. Analysts are cautious, with mixed sentiment and downward revisions in price targets.
